FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991383530> ?p ?o ?g. }

• W1991383530 endingPage "E338" @default.
• W1991383530 startingPage "E332" @default.
• W1991383530 abstract "In Brief Study Design. We measured the response of the behavior and spinal glial activation to anti-nerve growth factor receptor (p75 neurotrophin receptor [p75NTR]) antibodies in the rat brachial plexus avulsion (BPA) model. Objective. The aim of this study was to investigate the effect of anti-p75NTR antibodies on nociceptive behavior and activation of spinal microglia in the rat BPA model. Summary of Background Data. Tanezumab (anti-nerve growth factor antibody) treatment is associated with pain reduction and improvement in function, but with several complications. Methods. Thirty male Wistar rats were used. In the BPA group, the C8–T1 roots were avulsed from the spinal cord with forceps at the lower trunk level and 10 μL of saline was applied locally (n = 10). In the anti-p75NTR group, the C8–T1 roots were avulsed and 10 μL of anti-p75NTR antibody was applied locally (n = 10). In a sham-operated group, the lower trunk was simply exposed (n = 10). Mechanical hyperalgesia and pain-induced walking patterns were measured using von Frey filaments (Stoelting, Wood Dale, IL) and the CatWalk gait analysis (Noldus Information Technology, the Netherlands) system every third day for 3 weeks. Activation of astrocytes and microglia was immunohistochemically examined in the spinal cord using anti-glial fibrillary acidic protein (GFAP) and anti-Iba1 antibodies both 7 and 21 days after surgery. Results. Animals in the BPA group displayed significant mechanical hyperalgesia that continued through day 21 compared with animals in the sham-operated group, and mechanical hyperalgesia in the anti-p75NTR group was significantly improved 6 days after the operation. Regarding pain-induced gait analysis via CatWalk, animals in the BPA group displayed a significantly greater pain-like gait pattern than the p75 group for up to 3 weeks. Levels of GFAP-immunoreactive astrocytes and Iba1-immunoreactive microglia in the anti-p75NTR group were significantly reduced compared with the BPA group. Conclusion. Our results suggest that p75NTR contributes to neuropathic pain associated with BPA, and that inhibition of p75NTR reduces neuropathic pain. Level of Evidence: N/A We investigated the effect of inhibition of nerve growth factor receptor p75 neurotrophin receptor (p75NTR) on nociceptive behavior and activation of spinal glia after brachial plexus avulsion (BPA). p75NTR contributes to neuropathic pain associated with BPA, and that inhibition of p75NTR reduces neuropathic pain. p75NTR might represent a therapeutic target for the treatment of pain." @default.
• W1991383530 created "2016-06-24" @default.
• W1991383530 creator A5004155696 @default.
• W1991383530 creator A5004357209 @default.
• W1991383530 creator A5011530088 @default.
• W1991383530 creator A5013597034 @default.
• W1991383530 creator A5015241627 @default.
• W1991383530 creator A5019099819 @default.
• W1991383530 creator A5021773947 @default.
• W1991383530 creator A5032026810 @default.
• W1991383530 creator A5033234215 @default.
• W1991383530 creator A5041324850 @default.
• W1991383530 creator A5056566912 @default.
• W1991383530 creator A5067199915 @default.
• W1991383530 creator A5080980467 @default.
• W1991383530 creator A5087889642 @default.
• W1991383530 date "2013-03-01" @default.
• W1991383530 modified "2023-09-26" @default.
• W1991383530 title "The Effect of Anti-NGF Receptor (p75 Neurotrophin Receptor) Antibodies on Nociceptive Behavior and Activation of Spinal Microglia in the Rat Brachial Plexus Avulsion Model" @default.
• W1991383530 cites W1528167204 @default.
• W1991383530 cites W1617355594 @default.
• W1991383530 cites W1965779217 @default.
• W1991383530 cites W1967826700 @default.
• W1991383530 cites W1976228026 @default.
• W1991383530 cites W1985937673 @default.
• W1991383530 cites W1994174812 @default.
• W1991383530 cites W1995005137 @default.
• W1991383530 cites W2016151470 @default.
• W1991383530 cites W2027005712 @default.
• W1991383530 cites W2034056966 @default.
• W1991383530 cites W2044689537 @default.
• W1991383530 cites W2045960213 @default.
• W1991383530 cites W2059423055 @default.
• W1991383530 cites W2065482131 @default.
• W1991383530 cites W2071025088 @default.
• W1991383530 cites W2082122772 @default.
• W1991383530 cites W2082739481 @default.
• W1991383530 cites W2084103197 @default.
• W1991383530 cites W2087757288 @default.
• W1991383530 cites W2090245578 @default.
• W1991383530 cites W2090998770 @default.
• W1991383530 cites W2094584128 @default.
• W1991383530 cites W2099173554 @default.
• W1991383530 cites W2121270079 @default.
• W1991383530 cites W2128412489 @default.
• W1991383530 cites W2134905207 @default.
• W1991383530 cites W2137979524 @default.
• W1991383530 cites W2140441724 @default.
• W1991383530 cites W2162471211 @default.
• W1991383530 cites W2171156073 @default.
• W1991383530 cites W2172201406 @default.
• W1991383530 doi "https://doi.org/10.1097/brs.0b013e318285ee20" @default.
• W1991383530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23324933" @default.
• W1991383530 hasPublicationYear "2013" @default.
• W1991383530 type Work @default.
• W1991383530 sameAs 1991383530 @default.
• W1991383530 citedByCount "16" @default.
• W1991383530 countsByYear W19913835302013 @default.
• W1991383530 countsByYear W19913835302014 @default.
• W1991383530 countsByYear W19913835302015 @default.
• W1991383530 countsByYear W19913835302016 @default.
• W1991383530 countsByYear W19913835302017 @default.
• W1991383530 countsByYear W19913835302018 @default.
• W1991383530 countsByYear W19913835302019 @default.
• W1991383530 countsByYear W19913835302020 @default.
• W1991383530 countsByYear W19913835302022 @default.
• W1991383530 crossrefType "journal-article" @default.
• W1991383530 hasAuthorship W1991383530A5004155696 @default.
• W1991383530 hasAuthorship W1991383530A5004357209 @default.
• W1991383530 hasAuthorship W1991383530A5011530088 @default.
• W1991383530 hasAuthorship W1991383530A5013597034 @default.
• W1991383530 hasAuthorship W1991383530A5015241627 @default.
• W1991383530 hasAuthorship W1991383530A5019099819 @default.
• W1991383530 hasAuthorship W1991383530A5021773947 @default.
• W1991383530 hasAuthorship W1991383530A5032026810 @default.
• W1991383530 hasAuthorship W1991383530A5033234215 @default.
• W1991383530 hasAuthorship W1991383530A5041324850 @default.
• W1991383530 hasAuthorship W1991383530A5056566912 @default.
• W1991383530 hasAuthorship W1991383530A5067199915 @default.
• W1991383530 hasAuthorship W1991383530A5080980467 @default.
• W1991383530 hasAuthorship W1991383530A5087889642 @default.
• W1991383530 hasConcept C118552586 @default.
• W1991383530 hasConcept C126322002 @default.
• W1991383530 hasConcept C134018914 @default.
• W1991383530 hasConcept C15490471 @default.
• W1991383530 hasConcept C170493617 @default.
• W1991383530 hasConcept C204232928 @default.
• W1991383530 hasConcept C2776914184 @default.
• W1991383530 hasConcept C2777883359 @default.
• W1991383530 hasConcept C2778423431 @default.
• W1991383530 hasConcept C2779245659 @default.
• W1991383530 hasConcept C2779830541 @default.
• W1991383530 hasConcept C2780495277 @default.
• W1991383530 hasConcept C2780775167 @default.
• W1991383530 hasConcept C2781151446 @default.
• W1991383530 hasConcept C42219234 @default.
• W1991383530 hasConcept C71924100 @default.
• W1991383530 hasConcept C92020748 @default.

• next